Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular endothelium regeneration refers to the restoration or repair of the endothelial cell layer that lines blood vessels. This is not a single molecular target but rather a complex biological process involving multiple cellular and molecular pathways. The endothelium plays critical roles in maintaining vascular homeostasis, regulating blood flow, preventing thrombosis, and controlling inflammation. Regeneration can occur through several mechanisms: - Proliferation and migration of existing mature endothelial cells. - Recruitment and differentiation of endothelial progenitor cells from bone marrow or circulating sources. - Direct reprogramming of somatic cells into functional endothelial cells using transcription factors like ETV2 or by activating innate immune pathways such as TLR3. - Paracrine effects mediated by exosomes carrying pro-regenerative signals including growth factors like VEGF-A/C/D, FGF2/bFGF, TGFβ. Therapeutically enhancing vascular endothelium regeneration is being explored for treating cardiovascular diseases (such as ischemia), wound healing deficits, metabolic disorders with microvascular complications, and other conditions where vessel integrity is compromised. However, because this term describes a regenerative *process* rather than an individual protein/receptor/enzyme/transporter/etc., it does not fit standard definitions for therapeutic targets. Therefore: — "Vascular endothelium regeneration" should not be considered a canonical drug target but instead represents an important physiological phenomenon relevant to many disease states. — If structured data on specific molecules involved in this process are needed (e.g., "Vascular endothelial growth factor receptor 2"), those should be specified individually.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelium regeneration.